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Background: There has been no large study characterizing selection bias in allergy and evaluating school
personnel’s ability to use an epinephrine auto-injector (EpiPenW). Our objective was to determine if the consent
process introduces selection bias by comparing 2 methods of soliciting participation of school personnel in a study
evaluating their ability to demonstrate the EpiPenW.
Methods: School personnel from randomly selected schools in Quebec were approached using a 1) partial or 2) full
disclosure approach and were assessed on their ability to use the EpiPenW and identify anaphylaxis.
Results: 343 school personnel participated. In the full disclosure group, the participation rate was lower: 21.9% (95%
CI, 19.0%-25.2%) versus 40.7% (95%CI, 36.1%-45.3%), but more participants achieved a perfect score: 26.3% (95%CI,
19.6%-33.9%) versus 15.8% (95%CI, 10.8%-21.8%), and identified 3 signs of anaphylaxis: 71.8% (95%CI, 64.0%-78.7%)
versus 55.6% (95%CI, 48.2%-62.9%).
Conclusions: Selection bias is suspected as school personnel who were fully informed of the purpose of the
assessment were less likely to participate; those who participated among the fully informed were more likely to
earn perfect scores and identify anaphylaxis. As the process of consent can influence participation and bias
outcomes, researchers and Ethics Boards need to consider conditions under which studies can proceed without full
consent. Despite training, school personnel perform poorly when asked to demonstrate the EpiPenW.
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Food allergy is a serious condition affecting 3.9% of
children in the United States [1], and can lead to systemic
life-threatening symptoms or anaphylaxis [2]. There is
currently no well-established curative treatment for food
allergy and management relies on avoidance and therapy
with epinephrine for reactions caused by accidental* Correspondence: nha.nguyenluu@mail.mcgill.ca
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distribution, and reproduction in any mediumexposures [3]. We and others have shown that despite
increasing societal awareness of the potentially fatal
consequences of food allergy, accidental exposures
continue to occur [4-8] and about 10% of fatal food-
associated anaphylactic reactions take place in school
[9,10]. As school represents a situation where parents
must rely on other caregivers to respond to a severe aller-
gic reaction, school personnel must be able to recognize
anaphylaxis and know how to administer epinephrine
using an auto-injector device such as the EpiPenW [11]. A
delay in epinephrine administration substantially increases
the risk for fatality [10,12,13].ntral Ltd This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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not well prepared to recognize and treat food-induced
allergic reactions and anaphylaxis [14,15]. However, there
has not been any large study evaluating the ability of
school personnel to administer an epinephrine auto-
injector such as the EpiPenW. A brief report in 2005
showed that only 12% of 100 elementary school teachers
in Ontario, Canada correctly demonstrated the use of
the EpiPenW [16]. However, in a recent electronic survey
of 724 school teachers in Canada (published only in
abstract form), 82% of the respondents reported receiv-
ing training from health professionals or parents in using
the auto-injector and 80% claimed they were confident
in using it [17]. In contrast to the Ontario experience,
these teachers were not actually evaluated on their ability
to use the auto-injector. As part of a Canadian-wide
study examining the influence of different provincial
policies on the recognition and management of anaphyl-
axis in schools [18], our research team assessed the
ability of school personnel in Quebec to demonstrate the
EpiPenW technique and identify symptoms of anaphyl-
axis. In the other Canadian provinces, school personnel
were fully informed of the purpose of the assessment (i.e.,
full disclosure). However, it was anticipated that such full
disclosure may result in volunteer or consent bias, a form
of selection bias where those who volunteer or consent to
participate differ from those who do not, leading to an
incorrect assessment of performance capacity [19-21]. In
Quebec, we explored the potential role of volunteer or
consent bias by approaching school personnel in 2 differ-
ent ways: 1. A partial disclosure approach in which school
personnel were not notified in advance of the EpiPenW
demonstration and 2. A full disclosure approach in which
school personnel were informed in advance that they
would have to demonstrate the use of the EpiPenW. In this
manuscript, the participation rates and outcomes of these
2 groups were compared to determine if a volunteer or a
consent bias was present.
Methods
Selection of participants
In 2008, 2 school boards out of 10 within 1 h of tra-
veling time from downtown Montreal, Quebec were
randomly selected. Initially, 20 schools, including elem-
entary (kindergarten – grade 6) and secondary schools
(grade 7 – 11), were randomly identified within each
selected school board in a 4:1 ratio, representing the
ratio of elementary to secondary schools in Quebec
[22]. Following the approval by school boards and the
principals of the selected schools, the school secretary
was contacted to arrange a time for the assessors to
visit the school. Once a time was arranged, the research
team provided invitations (detailing date, time, location)
to the school secretary for distribution to all schoolstaff. If a school board or a school refused to participate
or did not provide an answer within 6 months after
multiple contacts, another one was randomly selected
to replace it. All school personnel, including teachers,
lunch monitors, administrative staff, school nurses, and
janitors, were invited to participate.
Methods of approaching school personnel
In the other Canadian provinces where the ability of
school personnel to recognize anaphylaxis and adminis-
ter an epinephrine auto-injector was also assessed, the
investigators were required by their Research Ethics
Boards to fully disclose the purpose of the assessor’s visit
in advance to participating school personnel. However,
because we suspected that such an approach might
introduce bias, in Quebec, the partial and full disclosure
approaches were compared. One of the selected school
boards was randomly assigned to a partial disclosure
approach, i.e. school personnel and school contacts were
not informed in advance of the EpiPenW demonstration
and were told in the study invitation that the investiga-
tors were studying school personnel’s knowledge “regard-
ing allergies and how schools are prepared for children
with allergies.” The 2nd school board was assigned to a
full disclosure approach: school personnel were informed
in the study invitation of the exact purpose of the asses-
sor’s visit, i.e., they would be asked to “show how they use
an EpiPenW to help students with life-threatening allergies
(anaphylaxis).” Both groups were told in the invitation
that they would be provided “feedback, education, and
materials on helping students with allergies in school.”
For both groups, on the day of the visit, prior to the
assessment, all school personnel who were interested
presented themselves to the assessor and were requested
to sign an informed consent which informed them that
they would be asked to demonstrate the use of the
EpiPenW. It should be noted that no participants in the
partial disclosure group refused to participate at this stage.
EpiPenW assessment
Although there are 2 epinephrine auto-administration
devices on the market in Canada, the TwinjectW was only
introduced in the fall of 2005 and has had relatively
limited uptake. In addition, the Quebec Ministry of
Health and Social Services stipulated that school
personnel that are not trained health care workers are not
allowed to administer the 2nd dose of the TwinjectW [23],
making this device less favored in the school environment.
Therefore, it was decided to only assess the EpiPenW
technique. Since we have completed the assessment
of the school personnel, the company producing the
EpiPenW has released a new EpiPenW device, which has
a slightly different shape and color. However, the steps
required to use the EpiPenW remain the same.
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and May 2009. The assessment visit for each school was
concluded within one day; there were no repeat visit to
schools. A location in the school was secured to allow
for privacy and a one-to-one interface with the assessor.
Assessors were trained nurses or allergists, and their
technique was assessed and ensured for accuracy.
EpiPenW technique was assessed based on accurate
completion of 4 steps [24,25] using an auto-injector
demonstrator:
1. Removal of the grey safety cap;
2. Placement of the black tip against the mid-outer thigh;
3. Application of firm pressure until the device
activates (“click” heard);
4. Holding of the device in place for 10 s.
To calculate a score for each participant, one point
was assigned for successful completion of each step
(maximum 4 points).
Participants were also asked to verbally provide 3
symptoms or signs of anaphylaxis. The 1st 3 symptoms
or signs mentioned by the participant were recorded by
the assessor. The answers were evaluated using previously
published work on the definition and symptoms and signs
of anaphylaxis [26]. After the assessor evaluated the parti-
cipant’s EpiPenW technique and the participant answered
questions regarding previous training and indications
for administration of an epinephrine auto-injector, the
assessor provided feedback on the participant’s technique
and coaching until accurate technique was achieved.
Statistical analysis
Descriptive statistics were compiled for all variables. The
participation rate was defined as the number of school














Participation rate % 23.2
CI – Confidence Interval.number of school personnel as provided by school secre-
taries. Data were analyzed according to each step of the
EpiPenW technique regarding whether or not the step
was performed accurately and an overall accuracy score
was calculated. School personnel with a partial disclos-
ure approach were compared to those with a full disclos-
ure approach in terms of participation rate, scores and
capacity to provide indications for epinephrine
administration and the difference between groups and
confidence intervals (CI) were reported. Multivariate
logistic regression analyses were used to determine if the
method of approach (i.e., partial versus full disclosure)
was associated with accurate demonstration of the
EpiPenW technique after adjustment for confounders.
Potential confounders considered included type of school
(elementary or secondary), prior training of the school
personnel in the use of the EpiPenW, prior training by a
nurse, and prior training using an EpiPenW trainer. These
analyses were adjusted for clustering of participants within
schools by allowing the variance to differ between schools.
This study was approved by the Research Ethics Board
of the McGill University Health Center.Results
In the partial disclosure group, 33 schools were
approached and 9 schools participated (7 elementary, 2
secondary); 460 personnel were approached and 187
participated (40.7%, 95% CI, 36.1%-45.3%). In the full
disclosure group, 34 schools were approached and 11
participated (9 elementary, 2 secondary); 711 personnel
were approached and 156 participated (21.9%, 95% CI,
19.0%-25.2%) (Table 1).
The majority of participants in both groups were
teachers: 64.2% in the partial disclosure group and








40.7 21.9 18.7 (13.3, 24.1)
130 128
334 471
38.9 27.2 11.7 (5.2, 18.3)
57 28
126 240
45.2 11.7 33.6 (24.0, 43.2)











Teachers 65.3 64.2 66.7
Lunch monitors 18.1 21.9 13.5
Administrative staff 11.7 10.2 13.5
Nurses 0.9 1.6 0.0
Others 2.0 1.6 2.6
Personnel from elementary schools 75.2 69.5 82.1
Prior training
Overall 89.2 87.2 91.7
Elementary schools 91.5 91.5 91.4
Secondary schools 82.4 77.2 92.9
Prior training by nurse
Overall 93.8 95.1 92.3
Elementary schools 94.5 95.0 94.0
Secondary schools 91.4 95.5 84.6
Prior training using an EpiPenW demonstrator
Overall 66.2 76.1 54.9
Elementary schools 75.7 88.2 62.9
Secondary schools 34.3 43.2 19.2
N – Number of participants.
1 These data are missing for one school.
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were administrative staff; only 3 school nurses (0.9%)
participated. The vast majority of participants in both
groups (89.2%) reported previous training, most of
them having been trained by school nurses (93.8%). The
training involved practice with an EpiPenW demonstra-
tor for 76.1% in the partial disclosure and 54.9% in
the full disclosure group. More school personnel from
elementary schools reported training: 91.5% versus
82.4%, including training with an EpiPenW demonstra-
tor: 75.7% versus 34.3%.
The mean scores for the EpiPenW assessment were







0 3.5 1.6 (0.3, 4
1 10.0 7.6 (4.2, 1
2 32.4 43.5 (36.2,
3 33.5 31.5 (24.9,
4 20.6 15.8 (10.8,
Mean Score(95% CI) 2.58 2.52 (2.39,
N – Number of participants.
CI – Confidence Interval.versus 2.64 (95% CI, 2.46-2.83) in the full disclosure
group (Table 3). Overall, only 20.6% of participants had
a perfect 4 point score. Participants from the full
disclosure group were more likely to have a perfect
score: 26.3% (95% CI, 19.6%-33.9%) versus 15.8% (95%
CI, 10.8%-21.8%). Mean scores were also higher in
elementary schools: 2.67 (95% CI, 2.55-2.80) versus 2.28
(95% CI, 2.04-2.51) in secondary schools, and school
personnel from elementary schools were more likely
to earn a perfect score: 23.7% (95% CI, 18.7%-29.4%) versus
10.8% (95% CI, 5.1%-19.6%) in secondary schools (Table 4).
The multivariate logistic regression analysis showed








.7) 5.8 (2.7, 10.7) −4.1 (−8.2, 0.0)
2.4) 12.8 (8.0, 19.1) −5.2 (−11.7, 1.3)
51.0) 19.2 (13.4, 26.3) 24.2 (14.8, 33.7)
38.8) 35.9 (28.4, 44.0) −4.4 (−14.5, 5.7)
21.8) 26.3 (19.6, 33.9) −10.5 (−19.2, -1.8)
2.65) 2.64 (2.46, 2.83) −0.12 (−0.34, 0.11)












0 3.5 1.9 (0.6, 4.5) 8.4 (3.5, 16.6) −6.5 (−12.7, -0.3)
1 10.0 9.3 (6.1, 13.6) 12.0 (5.9, 21.0) −2.7 (−10.6, 5.1)
2 32.4 31.9 (26.3, 38.0) 33.7 (23.7, 44.9) −1.8 (−13.5, 9.8)
3 33.5 33.1 (27.4, 39.2) 34.9 (24.8, 46.2) −1.9 (−13.6, 9.9)
4 20.6 23.7 (18.7, 29.4) 10.8 (5.1, 19.6) 12.9 (4.4, 21.4)
Mean Score(95% CI) 2.58 2.67 (2.55, 2.80) 2.28 (2.04, 2.51) 0.4 (0.13, 0.66)
N – Number of participants.
CI – Confidence Interval.
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Ratio (OR) 2.6 (95% CI, 1.5-4.6). Prior training with an
EpiPenW demonstrator was also associated with accurate
demonstration of the EpiPenW technique: OR 5.3 (95%
CI, 2.6-10.7).
When considering the percentage of participants
correctly demonstrating each step of the EpiPenW tech-
nique (Table 5), there was no between group difference
for steps 1 (removal of the safety cap) and 4 (holding the
device in place for 10 s). However, those in the full
disclosure group were slightly more likely to perform
step 2 (placement of the black tip against the mid-outer
thigh) correctly: 59.6% (95% CI, 51.5%-67.4%) versus
45.1% (95% CI, 37.8%-52.6%). In contrast, those in the
partial disclosure group were slightly more likely to per-
form step 3 (application of firm pressure until the device
activates) correctly: 91.3% (95% CI, 86.3%-94.9%) versus
82.1% (95% CI, 75.1%-87.7%). However, because it is not
known if keeping the EpiPenW device against the thigh
for 10 s (step 4) is really necessary to ensure efficacy, we
also calculated participants’ scores based on accurate
completion of the first 3 steps described above. When
this last step is omitted, those in the full disclosure group
were more likely to complete steps 1 through 3 correctly:
51.3% (95% CI, 43.3%-59.4%) versus 31.0% (95% CI,
24.4%-38.2%).
Overall, 63% of participants were able to identify 3







Step 1 81,5 81.0 (74.6, 86.4)
Step 2 51,8 45.1 (37.8, 52.6)
Step 3 87,1 91.3 (86.3, 94.9)
Step 4 37,2 34.6 (27.8, 41.9)
CI – Confidence Interval.
Step 1 - Removal of the grey safety cap.
Step 2 - Placement of the black tip against mid-outer thigh.
Step 3 - Application of firm pressure until the devices activates (“click” heard).
Step 4 - Holding of the device in place for 10 s.the administration of epinephrine, more in schools with
full disclosure: 71.8% (95% CI, 64.0%-78.7%) versus 55.6%
(95% CI, 48.2%-62.9%).
Discussion
In this study, we explored the existence of volunteer or
consent bias by using 2 different methods to solicit the
participation of school personnel in research evaluating
competency in the use of an epinephrine auto-injector
(EpiPenW): partial disclosure and full disclosure. The
participation rate was higher in the partial disclosure
group (between group difference 18.7%, 95% CI, 13.3%-
24.1%) and participants from the full disclosure group
were more likely to earn a perfect score (between group
difference 10.5%, 95% CI, 1.8%-19.2%), demonstrate the 3
critical steps correctly (between group difference 20.3%,
95% CI, 10.0%-30.6%), and identify signs of anaphylaxis
(between group difference 16.2%, 95% CI, 6.2%-26.2%).
These results suggest the existence of a volunteer or
consent bias, a form of selection bias where individuals
who volunteer for a study may have specific characteris-
tics that distinguish them from non-volunteers and that
may affect outcomes; for example, participants may be
more likely to find the topic interesting and usually expect
to be evaluated positively [27]. In our study, school
personnel from the partial disclosure group were not
given all the information about the purpose of the study
and the EpiPenW assessment prior to the assessors’ visit.e EpiPenW assessment





82.1 (75.1, 87.7) −1.1 (−9.3, 7.2)
59.6 (51.5, 67.4) −14.5 (−25.0, -4.0)
82.1 (75.1, 87.7) 9.3 (2.0, 16.5)
40.4 (32.6, 48.5) −5.8 (−16.1, 4.5)
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participate because of concerns regarding their knowledge
and competence, but their performance was generally
poorer. In contrast, those in the full disclosure group were
completely aware of the purpose of the assessment and
those with a greater interest and possibly knowledge in
the topic were more willing to participate, leading to an
overestimation of competence relative to the general popu-
lation. It is also possible that those who chose to participate
also practised or prepared prior to the evaluation, enhan-
cing their performance. This suggests that the timing and
the process of informed consent can affect the participation
rate and the interpretation of the results. Although this
threat to the validity of a study that arises from the consent
process has been described previously [20,21,28,29], we are
the first to explore its influence in allergy research.
In comparing the 2 approaches, we tried to ensure that
the school boards were as similar as possible other than
in the detailing of the consent by randomly selecting
school boards of similar size in the same urban area. In
addition, in Quebec, as school nurses responsible for
school personnel training are employed by the Ministry
of Health and Social Services and not by individual
school boards, the EpiPenW training is less likely to be
influenced by school board environments and likely to
be reasonably similar throughout the province. Further,
we adjusted for possible differences between the partial
and full disclosure groups through regression analyses and
demonstrated that the full disclosure group continued to
perform more favourably. However, it is possible that the
school boards differed in ways we did not consider or were
unable to measure and these differences influenced the
performance of school personnel. It should be noted that
in the multivariate analysis, prior training with an auto-
injector and being in the full disclosure group were inde-
pendent predictors of a perfect score. Hence, although
fewer in the full disclosure group reported training than
those in the partial disclosure group, they still per-
formed better and we anticipate that had more in the
full disclosure group reported training, the between
group difference in performance would be even greater.
It is also possible that there was contamination within
and between groups. As it was not feasible to conduct all
school assessments on the same day, assessments were
staggered over an 8-month period. Hence, it is possible
that school personnel within the partial or full disclosure
group assessed early in the process communicated with
those in the partial disclosure group who were assessed
later, informing them of the purpose of the assessment.
Such contamination would likely minimize our between
group difference and make our assessment of selection
bias conservative. In addition, our analyses were adjusted
to take into account the grouping of participants by
school, and we found that the effects of within-schoolversus between-school variations were not significant, as
the size of the confidence intervals was only minimally
affected. Although it was not the purpose of this small
study, it would have been interesting to compare partici-
pants and non-participants in terms of their anaphylaxis
interest and knowledge to better characterize the bias
illustrated in this study.
Our results reporting that only 26.3% (95% CI, 19.6%-
33.9%) among the full disclosure group are able to ac-
curately demonstrate the use of the EpiPenW are dis-
turbing as they likely overestimate the competence of
school personnel. The 15.8% (95% CI, 10.8%-21.8%)
demonstrating correct usage in the partial disclosure
group is likely more representative, but it, too, is prob-
ably an overestimate as the most informed were still
more likely to participate even in this group. Although
personnel in elementary schools performed more
favourably, possibly because they feel younger children
are more reliant on them, only 23.7% (95% CI, 18.7%-
29.4%) were able to correctly use the EpiPenW. These
results are worrisome because it has been shown that
inability to use an epinephrine auto-injector may con-
tribute to a delay in the treatment of anaphylaxis
[11,30] which can increase the risk for fatality [10,12].
Given the poor performance observed despite 89.2% of
all participants reporting training, the quality and fre-
quency of school personnel training needs to be exam-
ined. In Quebec, school personnel are trained in allergy
and anaphylaxis management and EpiPenW use on a
regular basis [31]. However, the content and frequency
of training programs may vary as there are no provincial
guidelines. In our study, training involving an EpiPenW
demonstrator was associated with better performance.
Other authors have also recommended use of the auto-
injector training device and frequent review to increase
knowledge retention [11,15]. A training model using an
audio-visual presentation and written material on ana-
phylaxis and epinephrine administration followed by a
meeting with allergic children was developed for school
personnel in San Francisco in 2004, and significantly
increased knowledge and perceived self-efficacy in 53
participants [32]. Such a training model could be adapted
and studied in Canada.
Conclusions
Although Research Ethics Boards usually ask investiga-
tors to fully disclose the intended purpose of their
research to potential participants, we have shown that
the process of consent can influence participation and
bias outcomes. Investigators need to appreciate and
acknowledge the potential bias that may be introduced
by the consent process and attempt to fulfill ethical
requirements while minimizing bias. While respecting
participants’ rights, ethical issues regarding the consent
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whenever the scientific validity of results may be com-
promised. Researchers and Ethics Boards may need to be
educated on circumstances under which studies can
proceed without full prior disclosure. Further, we have
shown that despite being trained to recognize anaphyl-
axis and to administer epinephrine, school personnel
perform poorly when asked to demonstrate how to use
the EpiPenW. The content, quality and frequency of al-
lergy and anaphylaxis training programs for school
personnel have to be re-examined. As recommended by
numerous guidelines [33-35] and required by legislation
in at least one Canadian province [36], management
plans targeting allergies and anaphylaxis should be
introduced in schools to create a safer environment for
children with life-threatening allergies. Further studies
on the process of implementation and the impact of
such plans are also needed.
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